Dextromethorphan HBr 7.5 mg Oral Lozenge
RxNorm 2167801
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2167801 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dextromethorphan HBr 7.5 mg Oral Lozenge.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Dextromethorphan hydrobromide 7.5 mg Oral Lozenge
(Atom ID: 12335366)
PT
Designated preferred name (PT):
Dextromethorphan 7.5 mg oromucosal lozenge
(Atom ID: 11436364)
PSN
Prescribable Name (PSN):
Dextromethorphan HBr 7.5 mg Oral Lozenge
(Atom ID: 6368452)
FN
Full form of descriptor (FN):
Product containing precisely dextromethorphan 7.5 mg/1 each conventional release oromucosal lozenge (clinical drug)
(Atom ID: 11439694)
Patient Education
Dextromethorphan
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
[Learn More]
* Please review the disclaimer below.